NEW YORK (GenomeWeb) – Johnson & Johnson Innovation, New York State, and the New York Genome Center this week announced they are collaborating to launch a new JLABS in New York City. The 30,000-square foot facility, called [email protected], will be located at the New York Genome Center in Soho and will open in 2018. New York State is investing $17 million in funding, and the space will be open to biotech, pharmaceutical, medical device, and consumer health companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.